Saturday, January 28, 2023

Partner News

Defence Therapeutics

Defence Therapeutics announces exciting addition to its board of directors

Biotechnology specialists Defence Therapeutics has revealed today that Dr Riam Shammaa has been appointed to its board of directors. Dr Riam Shammaa, MD, is a...
new COVID vaccine

Defence Therapeutics successfully test new COVID vaccine

Defence Therapeutics has sensationally revealed that they have successfully completed studies of their new COVID vaccine in a non-rodent rabbit model. The innovative new COVID...
healthy lifestyle

Maintaining an active and healthy lifestyle as we age in a digital world

Maintaining optimal physical condition becomes increasingly paramount as we age; to better understand how to achieve an active and healthy lifestyle, Aquarate discusses with...
breast cancer

AccumTM variants successfully increase breast cancer treatment potency

Biotechnology experts Defence Therapeutics have revealed strong in vitro results of its AccumTM variants on the ADC breast cancer treatment called Enhertu® (fam-trastuzumab-deruxtecan-nxki), which...
cancer vaccine

Defence Therapeutics prepares to test its DC cancer vaccine against melanoma

Defence Therapeutics is finalising all required steps in preparation for a pre-IND meeting to initiate a phase I trial against melanoma using its DC cancer...
cold chain

Vaccine cold chain pioneers inaugurate new factory extension

Luxemburg-based vaccine cold chain specialists B Medical Systems have conducted the opening ceremony of their cutting-edge factory extension at its corporate headquarters. The factory extension...
breast cancer treatment

Defence Therapeutics embark on next stage of breast cancer treatment development

In a groundbreaking development, pioneering biotechnology company Defence Therapeutics has announced today it will be performing the final necessary studies before entering a Phase...
new COVID vaccine

Defence Therapeutics’ new COVID vaccine achieves successful testing

Biotechnology experts Defence Therapeutics have sensationally announced that their new COVID vaccine has demonstrated effectiveness in a non-rodent model. The new COVID vaccine – called...
HPV vaccine

Defence Therapeutics unveil novel HPV vaccine development programme

Industry-leading biotechnology company Defence Therapeutics has revealed that it will be establishing a high priority programme to develop a new HPV vaccine for cervical...
drug-delivery-Defence-Therapeutics

Defence Therapeutics selects new variants to optimise drug delivery

Following a thorough evaluation process, Defence Therapeutics has selected the eight most successful variants of its Accum™ drug delivery technology. Biotechnology company Defence Therapeutics continually works...
ADVOS-COVID-19

Organ support therapy ADVOS can effectively treat COVID-19 patients

A new study has demonstrated the efficacy of ADVOS organ support therapy in successfully treating COVID-19 patients. ADVOS, the new blood purification procedure from ADVITOS,...
Defence Therapeutics

Defence Therapeutics: At the forefront of biotech innovation

In this article, we examine the future landscape of the Biotech sector, looking at the companies Defence Therapeutics, MorphoSys, BioNTech, and Pfizer. Infectious diseases are...
Defence-Therapeutics

Defence Therapeutics partners with pharmaceutical experts

Biotechnology company Defence Therapeutics has partnered with a pharmaceutical consultancy to maximise the potential of its developments. In a bid to strengthen its development of...
B-Medical-Systems

B Medical Systems receives environmental backing for refrigeration products

Vaccine cold chain and medical refrigeration specialist B Medical Systems has received Energy Star certification for a range of its products. B Medical Systems’ 115V...
MS-drug

New drug offers hope for MS sufferers on World Brain Day

As medical experts urgently call for action to tackle MS, one company has developed a drug it believes can treat the condition by repairing...
XPhyto

XPhyto expands infection prevention offering with new acquisition

Lifesciences specialist XPhyto Therapeutics has recently acquired 3a Diagnostics in a bid to advance its infection-prevention solutions. The move is the latest development in XPhyto’s...
Sputnik-V-vaccine

B Medical Systems provides cold chain storage for Sputnik V vaccine rollout

Vaccine cold chain expert B Medical Systems has partnered with Dr. Reddy’s in the pan India rollout of the Sputnik V vaccines. As part of...
XPhyto therapeutics supplies Berlin test centres with PCR tests

XPhyto therapeutics supplies Berlin test centres with PCR tests

XPhyto Therapeutics Corp. has signed a master supply agreement with Beovita GmbH & Co. KG and Tackleberries GmbH for PCR Tests. Beovita GmbH & Co....
Collaboration formed to test efficacy of breast cancer therapy

Collaboration formed to test efficacy of breast cancer therapy

Defence Therapeutics Inc. has announced the establishment of a collaboration with the Curie Institute to evaluate the therapeutic efficacy of Accum-T-DM1 ADC in patient-derived...
Defence Therapeutics Accutox exhibits potent anti-cancer properties

Defence Therapeutics Accutox exhibits potent anti-cancer properties

Defence Therapeutics Inc. has announced a major breakthrough advance in its pre-clinical research program on its AccuTOX molecules as potent anti-cancer agents. The AccumTM technology...

Latest Health Partners

Latest Health eBooks

Pin It on Pinterest